For many people recovering from opioid or alcohol addiction, cravings, withdrawal symptoms, anxiety, sleep disruption, and fear of relapse can make early recovery difficult to sustain.
Medication-Assisted Treatment (MAT) combines FDA-approved medications with counseling and behavioral treatment. At Louisville Addiction Center, medication support is integrated into a broader recovery plan that may also include psychiatric care, relapse prevention, dual diagnosis treatment, and ongoing outpatient support.
MAT is not medication alone. The purpose is to reduce barriers such as cravings and physical distress so clients can participate more consistently in the therapeutic work of recovery.
Medication-Assisted Treatment is an evidence-based approach that combines medications with counseling, behavioral therapy, and clinical support for certain substance use disorders.
Depending on the medication and substance involved, MAT can help reduce cravings, manage withdrawal-related symptoms, block or reduce the effects of certain substances, and support treatment retention.
Medication decisions should be individualized. Substance use history, current medications, medical conditions, withdrawal risk, mental health symptoms, prior treatment, and recovery goals can all affect which approach is appropriate.
Early recovery can be physically and emotionally demanding. Medication may help create enough stability for a person to participate more fully in counseling, skill building, and relapse prevention.
Appropriate medications may decrease persistent cravings that can otherwise dominate attention during early recovery.
Some medications can reduce or prevent specific withdrawal symptoms, although medically risky withdrawal may require a higher level of care.
Greater physical stability may make it easier to attend therapy, participate in groups, and follow a recovery plan consistently.
Evidence-based medications for opioid use disorder are associated with meaningful reductions in overdose and mortality risk when appropriately used.
Opioid use disorder can involve powerful cravings and physical dependence, especially with fentanyl, heroin, and other opioids. Evidence-based medications can be an important part of treatment.
Medication selection and timing depend on clinical assessment. Not every medication is appropriate at every stage of withdrawal or recovery.
Buprenorphine is used to treat opioid use disorder by reducing withdrawal and cravings. Sublocade is an extended-release injectable formulation of buprenorphine used for appropriate patients after clinical evaluation.
Explore Opioid TreatmentExtended-release naltrexone blocks opioid receptors and is used for relapse prevention in appropriate patients who have completed the required opioid-free period before initiation.
Explore Fentanyl TreatmentMedication can also be used as part of treatment for alcohol use disorder. The goal may include reducing cravings, supporting abstinence, or helping decrease the reinforcing effects of alcohol.
Alcohol withdrawal can become medically dangerous. Seizures, hallucinations, severe confusion, or delirium tremens require urgent medical evaluation and should not be managed as routine outpatient withdrawal.
Several FDA-approved medications are used for alcohol use disorder. The appropriate option depends on medical history, current alcohol use, liver and kidney considerations, other medications, and recovery goals.
Explore Alcohol TreatmentPeople at risk for severe alcohol withdrawal may need medically supervised detoxification before transitioning into outpatient addiction treatment.
Learn About Detox CoordinationMedication can address important biological aspects of addiction, but it does not by itself teach coping skills, repair relationships, resolve trauma, or change the behavioral patterns that contribute to relapse.
Therapy remains central because recovery also involves learning how to respond differently to stress, triggers, painful emotions, and high-risk situations.
CBT can help identify thought patterns, triggers, and behaviors associated with substance use and replace them with healthier responses.
Explore CBTTreatment can identify warning signs, high-risk situations, coping responses, and practical steps to take before a lapse becomes a full return to use.
Family work can improve communication, boundaries, and recovery support at home.
Explore Family TherapyWhen trauma is part of the clinical picture, treatment can address symptoms carefully without treating medication as a substitute for trauma therapy.
Explore Trauma TherapyMany people entering addiction treatment also experience depression, anxiety, PTSD, panic symptoms, grief, chronic stress, or other mental health concerns.
Once substance use decreases, some emotional symptoms may become more noticeable. An integrated treatment plan can address both addiction and mental health rather than assuming medication for substance use will resolve every underlying concern.
Louisville Addiction Center can incorporate dual diagnosis treatment when co-occurring mental health symptoms require coordinated care.
Treatment plans are individualized around the person’s substance use history, symptoms, mental health needs, medication needs, daily responsibilities, and recovery progress.
MAT may be incorporated into an outpatient level of care when clinically appropriate.
PHP provides a highly structured outpatient schedule for people who need substantial therapeutic support without 24-hour residential care.
Explore PHPIOP provides frequent therapy and recovery support with more flexibility for work, school, or family responsibilities.
Explore IOPOutpatient treatment can support continued therapy, medication monitoring, relapse prevention, and longer-term recovery maintenance.
Explore OutpatientClinical follow-up can assess medication response, side effects, adherence, recovery progress, and whether changes to the treatment plan are appropriate.
MAT begins with clinical assessment rather than choosing a medication based only on preference. The treatment team needs enough information to determine whether medication is appropriate and how it can be used safely.
The assessment reviews substances used, frequency, route, recent use, overdose history, withdrawal experiences, and previous treatment.
Current prescriptions, medical conditions, allergies, pregnancy considerations, and other health factors can affect medication selection.
Depression, anxiety, trauma, suicidal thoughts, psychosis, and other symptoms may change the immediate treatment plan or level-of-care recommendation.
Medication planning should reflect the client’s goals while also accounting for safety, evidence, and clinical appropriateness.
There is no universal MAT timeline. Some people use medication for a shorter period, while others benefit from maintenance treatment for months or longer.
Decisions about continuing, adjusting, or discontinuing medication should be made with the prescribing clinician rather than based on stigma or an arbitrary deadline.
When tapering is appropriate, it should be planned carefully. Abruptly stopping certain medications can increase withdrawal, cravings, or relapse risk.
Long-term recovery involves more than controlling cravings. Treatment should help clients build routines and supports that remain useful as work, relationships, responsibilities, and everyday stress return.
Continued counseling can address triggers, emotional patterns, relationships, and recovery goals as circumstances change.
Regular clinical review helps determine whether the medication continues to be effective, safe, and aligned with treatment goals.
A clear plan can identify warning signs, support contacts, overdose-prevention considerations, and when a higher level of care may be needed.
Healthy routines, peer support, family involvement when appropriate, and consistent appointments can reinforce stability beyond the initial phase of treatment.
Insurance coverage for MAT varies by plan, medication, pharmacy or medical benefit, network status, prior authorization requirements, deductible, and recommended level of care.
Admissions can review available benefits and explain what is known before treatment begins.
Provide your insurance information so the admissions team can review available treatment benefits.
Verify InsuranceDiscuss current substance use, medication questions, withdrawal concerns, and the next appropriate step in treatment.
Contact AdmissionsMedication-Assisted Treatment combines approved medications with counseling, behavioral treatment, and clinical support for certain substance use disorders.
No. When prescribed and monitored appropriately, medications used for substance use disorders are medical treatments. Physical dependence on a medication is not the same as uncontrolled addictive use.
Yes. Evidence-based medications for opioid use disorder can reduce cravings and withdrawal and are associated with lower overdose and mortality risk. The appropriate medication depends on individual clinical assessment.
Yes. FDA-approved medications are available for alcohol use disorder. Medication choice depends on medical history, current alcohol use, other medications, and treatment goals.
Yes. MAT is designed to combine medication with behavioral and recovery support. Therapy can address triggers, coping skills, relationships, trauma, mental health symptoms, and relapse prevention.
There is no single timeline. Duration should be individualized based on response to treatment, relapse risk, preferences, clinical stability, and guidance from the prescribing clinician.
It depends on the substance, medication, recent use, and withdrawal risk. Some medications have specific initiation requirements, and medically dangerous withdrawal may require supervised detoxification first.
Coverage varies by insurance plan and medication. Benefits may involve medical, behavioral health, and pharmacy coverage as well as prior authorization or network requirements.
Contact Louisville Addiction Center for an assessment. Admissions can discuss your current situation, verify available benefits, and help determine an appropriate next step.
Cravings, withdrawal concerns, and repeated relapse can make recovery feel difficult to sustain, but evidence-based treatment can reduce those barriers.
Louisville Addiction Center can help determine whether MAT is appropriate, explain available outpatient treatment options, review insurance benefits, and develop a treatment plan that combines medication with the therapeutic support needed for longer-term recovery.
American Psychological Association. (n.d.). Evidence‑based treatment for opioid use disorder. APA Publications. https://www.apa.org/topics/substance-use-abuse-addiction/evidence-based-treatment-opioids Clean Slate Centers+15Louisville Addiction Center+15Louisville Addiction Center+15American Psychological Association
Best Practices: Medication‑Assisted Treatment. (n.d.). Vital Alabama / MH Alabama PDF. https://vitalalabama.com/wp-content/uploads/2022/10/MAT-Digital-PDF_10-6.pdf VitAL Alabama
Jermyn, J. (2022). Review of medication‑assisted treatment for opioid use disorder. Journal of Osteopathic Medicine, 122(7). https://doi.org/10.1515/jom-2021-0163 Recovery.com+15De Gruyter Brill+15SAGE Journals+15
SAMHSA. (n.d.). Medication‑Assisted Treatment Models of Care for Opioid Use Disorder in Primary Care Settings: Technical Brief. SAMHSA Evidence‑Based Practices Resource Center. https://www.samhsa.gov/resource/ebp/medication-assisted-treatment-models-care-opioid-use-disorder-primary-care-settings SAMHSA+1
The American Journal of Managed Care. (n.d.). An overview of medication‑assisted treatment for opioid and alcohol use disorders. AJMC. https://www.ajmc.com/view/an-overview-of-medication-assisted-treatment-for-opioid-and-alcohol-use-disorders
Hear directly from those who have walked the path to recovery. Our patients’ stories highlight the compassionate care, effective programs, and life-changing support they’ve experienced. Let their journeys inspire you as you take your first steps toward healing.
